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INTRODUCTION
Following the initial case of SARS-CoV-2 diagnosed in a South 
African traveller on 5 March 2020, case numbers have con-
tinued to rise with approximately 35 800 cases and 755 deaths 
reported as of 2 June. The South African national response 
comprised eight overlapping stages, largely directed by a high-
level advisory team, which was tasked with establishing evi-
dence-based policy guidelines.(1)
Repercussions from the rising incidence of COVID-19 on the 
delivery of cardiac surgical services were noted and reported 
from Italy.(2) Specifically, it was noted that the exponential 
rise in COVID-19 cases resulted in a reallocation of ICU 
resources, with the drastic curtailment of elective cardiac sur-
gery due to lack of ICU beds and a concern of the well docu-
mented adverse outcomes in patients developing COVID 
infections peri-operatively. A modification of the traditional 
workflow was proposed, with the establishment of a “hub and 
spoke” model to ensure secure COVID and non-COVID 
pathways for patients. In addition, nasal swab testing was 
undertaken on all patients admitted to hospital, and a further 
thoracic computed tomography (CT) scan was undertaken on 
all patients admitted for urgent cardiac surgery to facilitate the 
diagnosis of COVID-19. 
In the South African cardiothoracic surgery context, we must 
be cognisant of a pre-existing inefficient and overwhelmed 
public health service with long waiting lists, and with a chronic 
shortage of operating lists and post-operative ICU beds. The 
location of state cardiac units within a single large regional 
hospital precludes a “hub and spoke” model of organisation. In 
contrast, the highly efficient private healthcare sector has 
numerous cardiac surgical units within the same geographic 
referral base in urban areas, and yet these units function 
competitively with profit generation as the primary goal – 
thereby excluding any form of collaboration to create a “hub 
and spoke” model. Both private and state cardiac surgical units 
require restructuring to allow for COVID, non-COVID and 
Persons Under Investigation (PUI) pathways. 
SURGERY FOR ACQUIRED HEART DISEASE
The disruption of adult cardiac surgery programmes has 
resulted in a risk-adjusted approach to elective and semi-urgent 
surgery. Procedures that are amenable to catheter-based 
therapies, such as transcatheter aortic valve implantation (TAVI) 
and percutaneous coronary interventions (PCI), may be 
favoured over traditional open-heart surgery due to the shorter 
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operative, intensive care and overall hospital stay, resulting in a 
lower risk of exposure to hospital for these patients. In addi-
tion, a tiered risk model has been formulated to guide the 
timing of surgery during incremental levels of COVID-19 in-
hospital burden (Table I).(3) 
During the peak of the pandemic, these considerations need 
to be weighed against a dramatically increased surgical mortality 
in COVID-19 patients. In a recent international multicentre 
cohort study at 235 hospitals in 24 countries, the outcomes of 
patients undergoing surgery with SARS-CoV-2 infection con-
firmed within 7 days before or 30 days after surgery were 
analysed. Postoperative pulmonary complications occurred in 
half of patients with perioperative SARS-CoV-2 infection, and 
were associated with a mortality rate of 24%. The study recom-
mended that the threshold for cardiac surgery during the 
COVID-19 pandemic be substantially higher than during normal 
practice, especially in men over the age of 70 years. Con-
sideration should be given to rescheduling non-urgent pro-
cedures and promoting non-operative treatment to delay or 
avoid the need for surgery.(4)
COVID-19 infection has been documented in heart transplant 
recipients, with the severity of disease ranging from a mild to 
severe respiratory illness.(5) The effects of COVID-19 in an 
immunosuppressed population may result in significant mor-
bidity with a mortality rate of up to 25%.(6) Careful considera-
tion should be given to organ transplantation programmes 
during the peak of the pandemic – weighing up the significant 
risk of transplantation in a COVID setting against the risk of 
death on the waiting list. Only high priority listed patients 
should be transplanted under these conditions.
Guidance documents have also emerged on the safe reintro-
duction and “ramping up” of surgical services in countries 
where the peak of the viral infection has passed.(7,8,9)
SURGERY FOR CONGENITAL HEART DISEASE
Guidelines for congenital cardiac surgery during the COVID-19 
pandemic include the routine screening of the child as well as 
the accompanying parents for symptoms of the disease. It is 
prudent to await the results of a SARS-CoV-2 nasal swab of 
the patient prior to admission for congenital heart surgery. 
Although vertical transmission of the disease has not been 
documented, all infants born to COVID positive mothers 
should be considered as persons under investigation (PUI) and 
tested accordingly. The timing of surgical intervention is deter-
mined by the clinical condition of the child, the cardiac pathol-
ogy, and the COVID status of the baby. Where reasonable, it 
may be appropriate to delay surgery in COVID positive patients 
until symptoms improve and/or repeat testing at 14 days 
confirms a negative result.(10)
The guidance document on the risk assessment approach to 
congenital cardiac surgery is not dissimilar to the standard 
TABLE I: Adapted from Adult cardiac surgery during the COVID-19 Pandemic: A Tiered Patient Triage Guidance Statement.(3)
Risk level Surgery undertaken
Tier 1
0% - 30% inpatient COVID-19 load
Mild reduction in operative capacity
All inpatients awaiting surgery (aortic dissection, acute coronary syndromes, acute valvular endocarditis, 
heart failure)
Outpatients at risk (critical aortic stenosis, high-risk coronary artery disease, cardiac tumours)
Aortic aneurysms, hypertrophic cardiomyopathy
High priority listed heart or lung transplants
Tier 2
30% - 60% inpatient COVID-19 load
Moderate reduction in operative capacity
All inpatients awaiting surgery
Outpatients with progressive symptomatic coronary artery disease 
Outpatients with asymptomatic coronary artery disease with impaired systolic function
High priority listed transplants
Tier 3
60% - 80% inpatient COVID-19 load
Severe reduction in operative capacity
All inpatients who cannot be discharged safely without surgical intervention/correction, including 
emergency services
High priority listed transplants who cannot be discharged from hospital
Tier 4
>80% inpatient COVID-19 load
Minimal operative capacity
Only emergency services based on resource availability
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guidelines on the surgical treatment of congenital heart disease 
(Table II).
GENERAL THORACIC SURGERY
International guidance on the risk-adjusted approach to tho-
racic surgery focuses on intrathoracic malignancies, using a 
triage system based on the overall burden of COVID-19 
disease within the hospital (Table III).(12) The role of non-
operative treatment strategies, such as neo-adjuvant chemo-
therapy, has been suggested as a viable alternative during all 
phases of the COVID-19 pandemic. 
The burden of thoracic surgical disease seen in South Africa is 
heavily skewed by the high incidence of HIV and co-morbid 
pulmonary tuberculosis in the population, presenting a unique 
challenge in the face of a respiratory viral illness such as 
COVID-19.(1) High risk urgent surgery for the sequelae of 
inflammatory lung disease, including active tuberculosis and 
drug resistant tuberculosis, may now be compounded by the 
presence of coexisting SARS-CoV-2 infection – increasing the 
surgical morbidity and risk of exposure to the surgical team in 
view of the aerosol-generating nature of lung resection surgery. 
TEACHING AND TRAINING PROGRAMMES
The interruption in the usual clinical workflow, combined with 
a reduction in surgical volumes and the redistribution of staff 
within cardiothoracic surgical programmes has disrupted many 
surgical training programmes. The transition from physical 
meetings to virtual meetings using online platforms has been 
made to ensure continuity of teaching through online journal 
clubs, clinical conferences, surgical audits and academic pre-
sentations. 
The online platform has facilitated international teaching 
through online presentations made by the Society of Thoracic 
Surgeons, the World Society of Paediatric and Congenital 
Heart Surgery, and the Indian Association of Cardiovascular-
Thoracic Surgeons. During the global lockdown, the American 
Association of Thoracic Surgery 100th annual meeting was 
converted from a physical meeting in New York in April 2020 
to a virtual meeting that took place in late May 2020, ensuring 
continuity of the international surgical education programme 
(https://www.aats.org/aatsimis/AATSWeb/Association/Meetings/
Annual_Meeting/100th_Annual_Meeting_Virtual/Program_
Highlights.aspx). 
TABLE II: Adapted from COVID-19: Crisis Management in Congenital Heart Surgery.(11)
Emergency
(24 - 48 hours of diagnosis)
Urgent
(Within 1 - 2 weeks)
High priority elective 
(>2 weeks)
Neonate Obstructed total anomalous 
pulmonary venous connection
Transposition of the great arteries with intact 
ventricular septum
Transposition with ventricular 
septal defect
Infant Shunt thrombosis Ventricular septal defect in cardiac failure
Tetralogy of Fallot with hypercyanotic spells
Failure to thrive
Children Thrombosed prosthetic mechanical valve Symptomatic valve lesions with cardiac failure Symptomatic valve lesions with 
cardiac failure
Adult Infective endocarditis with cardiogenic 
or septic shock
Right ventricle to pulmonary artery conduit 
stenosis, with severe ventricular dysfunction
Valve lesions with worsening 
cardiac failure
TABLE III: Adapted from the COVID-19 Guidance for Triage of Operations for Thoracic Malignancies: A Consensus Statement from Thoracic 
Surgery Outcomes Research Network. Ann Thorac Surg 2020.(12)
Phase I Phase II Phase III
Few COVID-19 patients in hospital
Adequate hospital resources 
Many COVID-19 patients
Resources limited (ICU beds, ventilators, 
clinicians, PPE)
Hospital resources are predominantly routed 
to COVID-19 patients
Resources critically limited/exhausted
Surgery restricted to patients who cannot 
be delayed for 3 months
Surgery restricted to patients who cannot 
be delayed for days
Surgery restricted to patients who cannot 
be delayed by hours
Examples: Bronchial carcinoma, oesophageal 
carcinoma, mediastinal tumours
Examples: Perforated oesophageal carcinoma, 
bronchial carcinoma resulting in infection/bleeding
Examples: Perforated oesophageal carcinoma, 
threatened airway, management of 
surgical complications
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Regarding operative training, surgical guidance documents 
suggest that the most experienced practitioner undertake all 
urgent surgery on patients with suspected or confirmed 
COVID-19 infection, in order to decrease the operative time 
and reduce the viral exposure to the surgical and theatre team. 
During the decline in COVID-19 cases volumes, it may be 
necessary for cardiac surgery training programmes to increase 
surgical volumes and extend training time in order to “catch 
up” with the surgical backlog. Academic programmes should 
maximise the clinical and operative training of surgeons once 
teaching hospitals are again considered “safe” for the practice 
of elective surgery. Failure to plan ahead and allocate sufficient 
resources in this regard may result in substantial surgical waiting 
lists, with increased morbidity and mortality.(13)
THE PROTECTION OF THE SURGICAL TEAM 
Cardiothoracic surgery is well versed in the creation and 
maintenance of sterile fields and infection control in general. 
Aggressive infection mitigation strategies in the operating 
room and surgical recovery have been proposed to reduce the 
risk to patients and the healthcare team.(14) The principles of 
improving safety for healthcare workers during the pandemic 
includes the use of non-operative management where feasible, 
patient testing within 48 hours prior to surgery, and the 
avoidance of emergency surgical procedures after hours. Car-
diothoracic surgical programmes require clear pathways for 
the triage of patients based on their COVID-19 status (posi-
tive or negative), as well as for patients under investigation 
(PUI). All staff members over the age of 60 years should not be 
involved in the care of COVID-19 patients, and surgical units 
should be divided into at least two teams that are able to 
function independently of each other in the event of an unex-
pected exposure to a COVID-19 positive patient, necessitating 
a period of quarantine.  
The nature of cardiothoracic surgery increases the exposure of 
staff to aerosol-generating procedures (AGPs) and necessitates 
the use of personal protective equipment (PPE), including an 
N95 mask, eye protection, gown and gloves in all confirmed or 
suspected COVID-19 patients. Ongoing donning and doffing 
training of PPE should be performed on a regular basis for con-
tinual refinement of the safety processes.
Guidelines regarding surgical processes include the transfer of 
patients directly to the operating theatre without stopping in a 
pre-operative holding area, all relevant precautions taken during 
airway manipulation (intubation) and electrosurgical use, and 
the post-procedure aerosol clearance of the operating theatre. 
A negative pressure operating room is considered ideal; insti-
tutions may however have difficulty in recalibrating existing 
positive pressure rooms. Alternatively, the operating room 
may remain positive pressure, but the surrounding rooms 
maintain a strict negative pressure ventilation system at >-2.5Pa 
at ≥12 air changes per hour. In addition, the use of video-
assisted thoracoscopic surgery has been discouraged due to 
the risk of aerosolisation and inadvertent lung injury.(14) 
The use of fast-tracking protocols has been promoted to 
reduce post-operative ventilatory requirements, and the early 
discharge of patients from hospital with online follow-up, where 
appropriate, is advocated. 
THE ROLE OF THE CARDIOTHORACIC 
SURGEON IN THE CARE OF THE CRITICALLY 
ILL COVID-19 PATIENT
As noted by our colleagues in Italy, increasing numbers of 
COVID-19 patients in a healthcare system quickly overwhelm 
the resources and may result in a shortage of physicians – 
themselves at risk of contracting the infection. 
Cardiothoracic surgeons may therefore find themselves on the 
frontline in the care of critically ill COVID-19 patients for a 
number of reasons: familiarity in managing ICU patients, the 
interpretation of detailed thoracic imaging studies (high reso-
lution CT scans), and the ability to obtain invasive vascular 
monitoring and access lines. More critically, the thoracic surgeon 
is entirely comfortable with airway management in these 
patients – ranging from intubation, bronchoscopy and airway 
toilet, through to tracheostomy.
In patients with severe hypoxia due to respiratory failure, the 
institution of extracorporeal membrane oxygenation (ECMO) 
falls within the gamut of the cardiothoracic surgical and per-
fusion team. The choice between veno-venous (VV) and veno-
arterial (VA) is largely dictated by the presence of associated 
COVID-19 related myocardial dysfunction. 
In a consensus document, the Extracorporeal Life Support 
Organisation (ELSO) outlined the principles of responsible 
ECMO use during the COVID-19 pandemic. These include 
providing extracorporeal life support in established ECMO 
units, the responsible use of ECMO based on system capacity 
and resource allocation, and the recommendation that ECMO 
support be offered preferentially to patients in whom out-
comes are favourable with ECMO runs that are relatively short 
and predictable.
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As of 1 June 2020, the ELSO had registered a total of 1 132 
patients with suspected or confirmed COVID-19 placed on 
ECMO, with 253/480 (52%) of patients surviving to discharge. 
Veno-venous (VV) ECMO was used in approximately 1 033 
patients (91%).
CONCLUSION
The role of cardiothoracic surgeons during the COVID-19 
pandemic continues to be modified and defined by the ever-
changing demands on the healthcare system at large. Our 
clinical practice during these uncertain times is assisted by 
guidance documents from professional societies in countries 
with a high burden of disease, such as the Society of Thoracic 
Surgeons (STS) in the United States and the European 
Association for Cardio-Thoracic Surgery (EACTS). Access to 
this experience ensures that we are able to best deliver quality 
care to our usual cohort of patients with intrathoracic disease, 
as well as patients with COVID-19 requiring advanced cardio-
thoracic surgical care. During these times, innovative solutions 
to local problems will be discovered (Smit, et al., in this issue), 
and in this spirit we shall strive to ensure that “Cardiac” lives 
will not be lost due to the overwhelming attention placed on 
saving “COVID” lives.
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